Nucleai and Jefferson Health Launch a Strategic Collaboration to discover novel Biomarkers
BC Platforms to Enable Longitudinal RWD and Genomics Access for Drug Development in Africa
Acquisition of Voluntis’ shares by AptarGroup,Inc
Debiopharm Statement regarding its Strategic Committee Members
Debiopharm interviewed by Biotech Finances to talk about our evergreen fund
Voluntis on receiving FDA 510(K) Clearance and expanding
Voluntis on receiving the CE Mark for Oleena
Voluntis expanding their global pharma collaborations
Novadiscovery announces new clinical simulation collaboration with Takeda
